Quantifying cardiovascular risk among patients with moderate to severe psoriasis

被引：0
|
作者：
Reich, K. [1 ]
Prinz, J. [2 ]
Szapary, P. [3 ]
Yeilding, N. [3 ]
Hsu, M. C. [3 ]
Li, S. [3 ]
Mrowietz, U. [4 ]
Kimball, A. B. [5 ]
Menter, A. [6 ]
机构：
[1] Univ Gottingen, Gottingen, Germany
[2] Univ Munich, Munich, Germany
[3] Centocor Res & Dev Inc, Malvern, PA USA
[4] Univ Kiel, Kiel, Germany
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Baylor Res Inst, Dallas, TX USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2008年 / 159卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1424 / 1424
页数：1
相关论文
共 50 条
  • [21] Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
    April W. Armstrong
    J. Will Koning
    Simon Rowse
    Huaming Tan
    Carla Mamolo
    Mandeep Kaur
    Clinical Drug Investigation, 2017, 37 : 493 - 501
  • [22] Effectiveness of guselkumab among patients with moderate-to-severe plaque psoriasis in the Corrona Psoriasis Registry
    Armstrong, April W.
    Callis-Duffin, Kristina
    Fitzgerald, Timothy
    Teeple, Amanda
    Uy, Jonathan
    Olurinde, Mobolaji
    Rowland, Katelyn
    McLean, Robert R.
    Guo, Lin
    Shan, Ying
    Van Voorhees, Abby S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB122 - AB122
  • [23] Initiation, Switching, and Cessation of Psoriasis Treatments Among Patients with Moderate to Severe Psoriasis in the United States
    Armstrong, April W.
    Koning, J. Will
    Rowse, Simon
    Tan, Huaming
    Mamolo, Carla
    Kaur, Mandeep
    CLINICAL DRUG INVESTIGATION, 2017, 37 (05) : 493 - 501
  • [24] DIAGNOSIS AND TREATMENT HISTORY BEFORE PSORIASIS DIAGNOSIS AMONG PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS
    Feldman, S. R.
    Zhao, Y.
    Hur, P.
    Liu, J. S.
    Herrera, V
    VALUE IN HEALTH, 2017, 20 (05) : A156 - A156
  • [25] Cardiovascular Risk Assessment in Moderate to Severe Inflammatory Arthritis Patients
    Alabdurubalnabi, Zainab
    Keeling, Stephanie
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1308 - 1308
  • [26] The cardiovascular assessment tool (cvat): assessing risk factors for cardiovascular disease in patients with moderate to severe psoriasis treated with fumaric acid esters
    Reich, K.
    Merten, K.
    Berenzen, N.
    Boehncke, W. -H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 2 - 3
  • [27] Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta-analysis
    Miller, I. M.
    Skaaby, T.
    Ellervik, C.
    Jemec, G. B. E.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) : 1180 - 1187
  • [28] Increase of cardiovascular risk in the presence of non-alcoholic fatty liver disease in patients with moderate-to-severe psoriasis
    Romero-Perez, D.
    Belinchon-Romero, I.
    Bellot, P.
    Frances, R.
    Marco, F.
    Ramos, J. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 58 - 58
  • [29] INCREMENTAL BURDEN OF CARDIOVASCULAR COMORBIDITY OR PSORIATIC ARTHRITIS AMONG INDIVIDUALS WITH MODERATE-TO-SEVERE PSORIASIS
    Augustin, M.
    Tian, H.
    Gilloteau, I
    Mollon, P.
    Vietri, J.
    VALUE IN HEALTH, 2016, 19 (03) : A126 - A126
  • [30] The effect of adalimumab on improving work productivity among moderate to severe psoriasis patients
    Kimball, Alexa B.
    Yu, Andrew P.
    Mulani, Parvez
    Gupta, Shiraz
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB180 - AB180
12345